Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/9/2025

Stimulant Medications for Adult ADHD

Efficacy and Response Rates

  • Stimulants as a class demonstrate 70-80% response rates for ADHD treatment in adults, making them the gold standard with the largest effect sizes compared to all other medication options 1
  • Methylphenidate specifically showed 78% improvement versus 4% placebo response in controlled trials of adults with ADHD at doses of 1 mg/kg total daily dose 2
  • The American Academy of Child and Adolescent Psychiatry recommends methylphenidate as a first-line treatment for adult ADHD, with response rates independent of gender, comorbidity, or family history of psychiatric disorders 2

Medication-Specific Evidence

  • Methylphenidate has the strongest evidence base and most robust clinical trial data among all ADHD medications, with the highest response rates documented 1
  • The American Academy of Child and Adolescent Psychiatry recommends adult dosing of 5-20 mg three times daily for immediate-release methylphenidate formulations 2
  • OROS-methylphenidate (Concerta) provides 12-hour coverage, the longest duration among methylphenidate formulations, and is resistant to diversion 2, 3
  • Newer extended-release methylphenidate formulations with early peak followed by 8-12 hours of action are superior to older sustained-release formulations 3

Comparative Considerations

  • Lisdexamfetamine offers the longest duration (13-14 hours) of symptom control, followed by OROS-methylphenidate (12 hours) and Adderall XR (8-9 hours) 3
  • The American Academy of Pediatrics recommends considering lisdexamfetamine or OROS-methylphenidate as first-line options for patients with substance abuse history due to lower abuse potential 4
  • Methylphenidate causes significantly less sleep disruption compared to amphetamines, making it preferable for patients with insomnia complaints 3

Treatment Algorithm

  • The American Academy of Child and Adolescent Psychiatry recommends starting with either methylphenidate or lisdexamfetamine as first-line therapy for adult ADHD 1
  • Switching between stimulant classes (methylphenidate to amphetamine or vice versa) is appropriate before abandoning stimulants entirely 1
  • The American Academy of Child and Adolescent Psychiatry recommends monitoring ADHD symptom severity using standardized rating scales at baseline and follow-up, as well as monitoring blood pressure and heart rate at baseline and regularly during treatment 1, 3